Protecta (Glucosamine sulphate, Chondroitine sulphate, Methylsulfonylmethane, Manganous gluconate dehydrate, Calcium, Vitamin D3)
COMPOSITION
One effervescent tablet contains:
Glucosamine sulphate – 750 mg
Chondroitine sulphate – 600 mg
Methylsulfonylmethane – 750 mg
Manganous gluconate dehydrate – 20 mg
Calcium – 500 mg
Vitamin D3 – 400 IU
THERAPEUTIC INDICATIONS
- Degenerative dystrophic diseases of joints and spine (including
osteochondrosis);
- Osteoarthrosis of I-III stage;
- Prophylaxis and complex treatment of osteoporosis and its complications (fractures);
- Compensation of calcium and D3 vitamin deficiency;
- As a part of rehabilitation actions following joint traumas.
ADVERSE EFFECTS
CNS disorders: dizziness, headache, somnolence, insomnia.
Metabolism disorders: hypercalcemia, hypercalciuria.
Gastrointestinal disorders: meteorism, diarrhea, constipation, upper abdominal
pains, nausea, abdominal pains.
Other: tachycardia, peripheral edema, scelalgia, allergic reactions.
DOSAGE AND ADMINISTRATION
Protecta is orally administered with mo regard to food intake. One tablet should
be completely dissolved in 200 ml of water of room temperature. Drink
immediately after the dissolution.
For prophylaxis, as a part of complex therapy of osteoporosis, as well as
calcium and D3 vitamin deficiency, 1 tablet of Protecta is administered 1-2
times daily. The duration of therapy and dosage regimen is determined according
to doctor’s recommendations.
In treatment of degenerative dystrophic diseases of joints and spine (including
osteochondrosis) and osteoarthrosis of I-III stage, during three first weeks 1
tablet of Protecta is administered twice daily, and during subsequent days 1
tablet is administered once daily. The duration of treatment is 3-6 months. If
needed, individually assigned course of retreatment may be prescribed.
INTERACTION WITN OTHER MEDICINAL PRODUCTS
Protecta depresses the action of semisynthetic penicillin and chloramphenicol,
potentiates the action of anticoagulants. Administered concurrently with
phenytoin or barbiturates, the decreased activity of Vitamin D may be observed.
Colestyramine or mineral oil or agricultural oil laxatives decrease the
absorption of D3 vitamin.
Applied concurrently with biophosphonates or sodium fluoride, the intake
interval should be no less than 2 hours. Applied concurrently with oral
tetracycline, the intake interval should be no less than 3 hours.
MANUFACTURED FORM
Effervescent tablets.
20 effervescent tablets in polypropylene tube, closed with propylene stopper
with silica gel.
1 tube with a leaflet in carton box.
|
 |
Musculo-Skeletal system
All Products
Artrocol
Artrocol Capsul
Artrocol Suppository
Benevron B
Benevron BF
Clodifen
Clodifen Capsul
Clodifen Gel
Clodifen Suppository
Drastop
Loxidol
Loxidol Injectable
Loxidol Tablet
Medrolgin
Muskomed Capsul
Muskomed Injection
Muskomed Krem
Protecta
Zoltonar
|